{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 1.9230828, "regularMarketPrice": 1.59, "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "exchange": "FRA", "shortName": "GALECTIN THERA.  DL-,01", "longName": "Galectin Therapeutics Inc.", "messageBoardId": "finmb_1065415", "exchangeTimezoneName": "Europe/Berlin", "marketState": "REGULAR", "firstTradeDateMilliseconds": 1172127600000, "priceHint": 4, "regularMarketChange": 0.03000009, "regularMarketTime": 1683880220, "regularMarketDayHigh": 1.59, "regularMarketDayRange": "1.59 - 1.59", "regularMarketDayLow": 1.59, "regularMarketVolume": 400, "regularMarketPreviousClose": 1.56, "bid": 1.54, "ask": 1.65, "bidSize": 2277, "askSize": 2190, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.59, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.64500004, "fiftyTwoWeekLowChangePercent": 0.6825397, "fiftyTwoWeekRange": "0.945 - 2.4", "fiftyTwoWeekHighChange": -0.81000006, "fiftyTwoWeekHighChangePercent": -0.3375, "fiftyTwoWeekLow": 0.945, "fiftyTwoWeekHigh": 2.4, "earningsTimestamp": 1680177600, "earningsTimestampStart": 1684151400, "earningsTimestampEnd": 1684497000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.57, "epsForward": -0.7, "epsCurrentYear": -0.6, "priceEpsCurrentYear": -2.6499999, "sharesOutstanding": 59462000, "bookValue": -0.579, "fiftyDayAverage": 1.7532, "fiftyDayAverageChange": -0.16320002, "fiftyDayAverageChangePercent": -0.093086936, "twoHundredDayAverage": 1.5306, "twoHundredDayAverageChange": 0.05940008, "twoHundredDayAverageChangePercent": 0.038808364, "marketCap": 94544584, "forwardPE": -2.2714286, "priceToBook": -2.746114, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Galectin Therapeutics, Inc.", "nameChangeDate": "2023-05-11", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "symbol": "PHPN.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4960 Peachtree Industrial Boulevard", "address2": "Suite 240", "city": "Norcross", "state": "GA", "zip": "30071", "country": "United States", "phone": "678 620 3186", "website": "https://galectintherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joel  Lewis", "age": 52, "title": "Pres, CEO & Director", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 870664, "fmt": "870.66k", "longFmt": "870,664"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jack W. Callicutt CPA, CPA", "age": 55, "title": "CFO, Treasurer & Corp. Sec.", "yearBorn": 1967, "fiscalYear": 2016, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pol F. Boudes M.D., Ph.D.", "age": 65, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 720637, "fmt": "720.64k", "longFmt": "720,637"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Robert  Tritt", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Beth  Knowles", "title": "Exec. Assistant & Officer Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}